Breakthrough Designation for Biomimetic OsStic Bone Void Filler

Biomimetic OsStic Bone Void Filler

Biomimetic Innovations' OsStic was granted Breakthrough Device designation by FDA.

The proposed indication statement for this novel new technology is, “OsStic Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation or void filling of peri-articular fractures or defects to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0